PAPER Salamone EM, Carpi M, Noce G, Percio CD, Lopez S, Lizio R, Jakhar D, Eldellaa A, Isaza VH, Bölükbaş B, Soricelli A, Salvatore M, Güntekin B, Yener G, Massa F, Arnaldi D, Famà F, Pardini M, Ferri R, Salerni M, Lanuzza B, Stocchi F, Vacca L, Coletti C, Marizzoni M, Taylor JP, Hanoğlu L, Yılmaz NH, Kıyı İ, Kula H, Frisoni GB, Cuoco S, Barone P, D'Anselmo A, Bonanni L, Biundo R, D'Antonio F, Bruno G, Giubilei F, Antonini A, Babiloni C

Abnormal electroencephalographic rhythms from quiet wakefulness to light sleep in Alzheimer's disease patients with mild cognitive impairment.

Clin Neurophysiol. 2025 Jan 31;171:164-181. Epub 2025 Jan 31 PubMed.

PAPER Kowa H, Kumagai R, Oki Y, Imamura M, Suzuki Y

Tablet-based self assessment memory scale-revised (SAMS-R) evaluates memory functions for older adults.

Front Aging Neurosci. 2024;16:1512947. Epub 2025 Jan 22 PubMed.

PAPER Noh MY, Kwon MS, Oh KW, Nahm M, Park J, Jin HK, Bae JS, Son B, Kim SH

miRNA-214 to predict progression and survival in ALS.

J Neurol Neurosurg Psychiatry. 2025 Feb 6; Epub 2025 Feb 6 PubMed.

PAPER Modiri A, Abdolmaleki Z, Paryani MR

The effect of rosuvastatin coated by nano-chitosan on developing hippocampus: association with hippocampal neurogenesis and memory in an Alzheimer's induced model of rats.

Anat Cell Biol. 2025 Feb 7; Epub 2025 Feb 7 PubMed.

PAPER Cai M, Zhang X, Gao X, Huo Q, Sun Y, Dai X

Chitooligosaccharide ameliorates cognitive deficits and neuroinflammation in APP/PS1 mice associated with the regulation of Nrf2/NF-κB axis.

Int J Biol Macromol. 2025 Feb 4;:140683. Epub 2025 Feb 4 PubMed.

PAPER Wei D, Freydenzon A, Guinebretiere O, Zaidi K, Yang F, Ye W, Hammar N, Modig K, Wray NR, Feychting M, Hamieh N, Ventelou B, Lekens B, Gantzer L, Durrleman S, McRae A, Couvy-Duchesne B, Fang F, Nedelec T, LeMeReND consortium

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

EBioMedicine. 2025 Feb 5;113:105585. Epub 2025 Feb 5 PubMed.

PAPER Gusain S, Mishra CB, Yadav K, Sharma M, Saluja D, Tiwari M

Development of carbazole-based molecules for inhibition of mutant hSOD1 protein aggregation in Amyotrophic Lateral Sclerosis.

Bioorg Med Chem. 2025 Jan 30;120:118091. Epub 2025 Jan 30 PubMed.

PAPER Madhagi HA, Nassar H

Harnessing network pharmacology and in silico drug discovery to uncover new targets and therapeutics for Alzheimer's disease.

Comput Biol Med. 2025 Feb 5;187:109781. Epub 2025 Feb 5 PubMed.

Go to another page:

12
13
14
15
16
... 23071

Current Filters

No filters selected

SEARCH RESULTS

Irisin promotes autophagy and attenuates NLRP3 inflammasome activation in Parkinson's disease.

Alpha-Synuclein Fails to Form Aggregates in Endocytosis-Defective Fission Yeast Strains, ∆ myo1 and ∆ end4.

Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives.

Brain network and energy imbalance in Parkinson's disease: linking ATP reduction and α-synuclein pathology.

Joint ensemble learning-based risk prediction of Alzheimer's disease among mild cognitive impairment patients.

Neuritin improves cognitive impairments in APP/PS1 Alzheimer's disease mice model by mitigating neuronal ferroptosis via PI3K/Akt activation.

Longitudinal analysis of objective and self-reported cognitive functions in individuals with subjective cognitive decline.